文献速递消化道肿瘤放疗放疗物理与技术

直肠癌新辅助放化疗后晚期小肠毒性的剂量学预测参数

Dosimetric Parameters Predicting Late Small Bowel Toxicity in Patients With Rectal Cancer Receiving Neoadjuvant Chemoradiation.
PubMed 文献 · Pract Radiat Oncol · 2020-08-07

本研究纳入486例接受新辅助长程放化疗后手术的局部晚期直肠癌患者,评估小肠照射剂量-体积与晚期小肠毒性的关系并建立预测模型。中位随访60个月,7.4%发生≥2级、4.3%发生≥3级晚期小肠毒性;V30与小肠毒性关联最强,将V30限制在<200 cm3可将5年≥3级晚期小肠毒性控制在<5%。

要点

  • V30是小肠晚期≥3级毒性关联最强的剂量学参数。
  • 预测≥3级毒性5%风险的V30为201.5 cm3。
  • 计划时将V30限制在<200 cm3可作为减少晚期毒性的参考。

核心结论

  • 小肠接受至少30 Gy的体积(V30)与晚期≥3级小肠毒性显著相关,限制V30<200 cm3有助于将5年≥3级晚期小肠毒性控制在<5%。

研究设计与样本

  • 单中心连续病例分析,纳入486例临床T3/T4或N1/N2的局部晚期直肠癌患者,均接受新辅助长程放化疗后手术且具备剂量学数据。
  • 评估小肠照射与晚期小肠毒性的剂量-体积关系,并推导预测晚期小肠毒性的数学模型。
  • 自放疗结束起中位随访60个月。

主要发现

  • 36例(7.4%)发生≥2级晚期小肠毒性,21例(4.3%)发生≥3级晚期小肠毒性。
  • 在5至40 Gy间每5 Gy间隔的各剂量水平上,≥3级晚期小肠毒性与受照小肠体积均呈统计学显著关联(所有剂量体积P < .001)。
  • 发生≥2级毒性者平均小肠体积为2149.9 cm3,发生≥3级毒性者平均小肠体积为2179.9 cm3。
  • V30与≥3级小肠毒性关联最强。

关键数值与推荐

  • ≥2级小肠毒性5%风险对应的预测V30为101.5 cm3。
  • ≥3级小肠毒性5%风险对应的预测V30为201.5 cm3。
  • 计划时将V30限制在<200 cm3,以将5年≥3级晚期小肠毒性控制在<5%。

临床怎么用

  • 直肠癌新辅助长程放化疗计划设计时,可将小肠V30<200 cm3作为剂量约束参考,以降低5年≥3级晚期小肠毒性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to identify dosimetric parameters that predict late small bowel (SB) toxicity after neoadjuvant long course chemoradiation (CRT) for rectal cancer. METHODS AND MATERIALS: Four hundred eighty-six consecutive patients with locally advanced rectal cancers (clinical T3/T4 or N1/N2) who received CRT followed by surgery and had dosimetric data available for analysis were included in this study. The dose-volume relationship between small bowel irradiation and late small bowel toxicity was evaluated and a mathematical model to predict for late SB toxicity was derived. RESULTS: Among the 486 patients with a median follow-up of 60 months from completion of radiation, 36 (7.4%) patients experienced ≥ grade 2 and 21 (4.3%) developed ≥ grade 3 late SB toxicity. A statistically significant association between the development of grade ≥3 late small bowel toxicity and the volume of small bowel irradiated was found at each dose level from 5 to 40 Gy (P < .001 for all dose volumes) in 5 Gy intervals. The average SB volume for patients who experienced grade ≥2 SB toxicity was 2149.9 cm3 and the average SB volume for patients who experienced grade ≥3 SB toxicity was 2179.9 cm3. The predicted V30 for a 5% risk for grade ≥2 SB toxicity was 101.5 cm3 and for grade ≥3 SB toxicity was 201.5 cm3. The volume of small bowel receiving at least 30 Gy (V30) was most strongly associated with grade ≥3 SB toxicity. CONCLUSIONS: This study demonstrates the significant dose-volume relationship between volume of small bowel receiving 30 Gy (V30 Gy) and late grade ≥3 SB toxicity. When planning CRT for patients with rectal cancer, restricting V30 to <200 cm3 will be a useful guideline to minimize the 5 year grade ≥3 late SB toxicity to <5%.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Abraham AG, Usmani N, Warkentin B, et al. Dosimetric Parameters Predicting Late Small Bowel Toxicity in Patients With Rectal Cancer Receiving Neoadjuvant Chemoradiation. Pract Radiat Oncol. 2020. PMID: 32771626. doi:10.1016/j.prro.2020.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。